Folfirinox in the treatment of advanced gastroenteropancreatic neuroendocrine carsinomas

被引：3
|
作者：
Butt, B. P. [1 ]
Stokmo, H. L. [2 ]
Ladekarl, M. [3 ]
Tabaksblat, E. Mitkina [4 ]
Sorbye, H. [5 ]
Revheim, M. E. [6 ]
Hjortland, G. O. [1 ]
机构：
[1] Oslo Univ Hosp, ENTES Neuroendocrine Tumor Ctr Excellence, Dept Oncol, Oslo, Norway
[2] Oslo Univ Hosp, Div Radiol & Nucl Med, Dept Nucl Med, Oslo, Norway
[3] Aalborg Univ Hosp, Clin Canc Res Ctr, Dept Oncol, Aalborg, Denmark
[4] Aarhus Univ Hosp, ENETS Neuroendocrine Tumor Ctr Excellence, Dept Oncol, Aarhus, Denmark
[5] Haukeland Univ Sykehus, Dept Clin Sci, Dept Oncol, Bergen, Norway
[6] Oslo Univ Hosp, ENETS Neuroendocrine Tumor Ctr Excellence, Inst Clin Med, Dept Nucl Med,Div Radiol & Nucl Med, Oslo, Norway
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1108P
引用
收藏
页码：S915 / S915
页数：1
相关论文
共 50 条
  • [1] Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors
    Allaw, Mohammed B.
    Switchenko, Jeffrey M.
    Khalil, Lana
    Wu, Christina
    Alese, Olatunji B.
    Akce, Mehmet
    Draper, Amber
    Jones, Aaron T.
    El-Rayes, Bassel
    Shaib, Walid
    ONCOLOGY, 2022, : 131 - 139
  • [2] Current status and future perspectives of treatment for advanced gastroenteropancreatic neuroendocrine neoplasms
    Fujimori, Nao
    ANNALS OF ONCOLOGY, 2023, 34 : S1366 - S1366
  • [3] Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?
    Rinke, Anja
    Auernhammer, Christoph J.
    Bodei, Lisa
    Kidd, Mark
    Krug, Sebastian
    Lawlor, Rita
    Marinoni, Ilaria
    Perren, Aurel
    Scarpa, Aldo
    Sorbye, Halfdan
    Pavel, Marianne Ellen
    Weber, Matthias M.
    Modlin, Irvin
    Gress, Thomas M.
    GUT, 2021, 70 (09) : 1768 - 1781
  • [4] Treatment of gastroenteropancreatic neuroendocrine tumors
    U. Plöckinger
    B. Wiedenmann
    Virchows Archiv, 2007, 451 : 71 - 80
  • [5] Treatment of gastroenteropancreatic neuroendocrine tumors
    Ploeckinger, U.
    Wiedenmann, B.
    VIRCHOWS ARCHIV, 2007, 451 (Suppl 1) : S71 - S80
  • [6] Systemic therapies for advanced gastroenteropancreatic neuroendocrine tumors
    Patel, Dainik
    Chan, David
    Cehic, Gabrielle
    Pavlakis, Nick
    Price, Timothy Jay
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (04) : 311 - 327
  • [7] Emerging Therapies for Advanced Gastroenteropancreatic Neuroendocrine Tumors
    Gupta, Sameer
    Engstrom, Paul F.
    Cohen, Steven J.
    CLINICAL COLORECTAL CANCER, 2011, 10 (04) : 298 - 309
  • [8] Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin
    J. Capdevila
    J. Hernando
    A. Teule
    C. Lopez
    R. Garcia-Carbonero
    M. Benavent
    A. Custodio
    A. Garcia-Alvarez
    A. Cubillo
    V. Alonso
    A. Carmona-Bayonas
    T. Alonso-Gordoa
    G. Crespo
    P. Jimenez-Fonseca
    M. Blanco
    A. Viudez
    A. La Casta
    I. Sevilla
    A. Segura
    M. Llanos
    S. Landolfi
    P. Nuciforo
    J. L. Manzano
    Nature Communications, 14
  • [9] Standard Treatment Recommendations for Advanced Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NECs)
    Smith, Abraham T.
    JOURNAL OF THE PANCREAS, 2022, 23 (07): : 68 - 69
  • [10] Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin
    Capdevila, J.
    Hernando, J.
    Teule, A.
    Lopez, C.
    Garcia-Carbonero, R.
    Benavent, M.
    Custodio, A.
    Garcia-Alvarez, A.
    Cubillo, A.
    Alonso, V.
    Carmona-Bayonas, A.
    Alonso-Gordoa, T.
    Crespo, G.
    Jimenez-Fonseca, P.
    Blanco, M.
    Viudez, A.
    La Casta, A.
    Sevilla, I.
    Segura, A.
    Llanos, M.
    Landolfi, S.
    Nuciforo, P.
    Manzano, J. L.
    NATURE COMMUNICATIONS, 2023, 14 (01)
12345